Perigon Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,554
| Closed | -$282K | – | 710 |
|
|
2022
Q3 | $282K | Sell |
2,554
-500
| -16% | -$55.2K | 0.02% | 435 |
|
|
2022
Q2 | $229K | Buy |
3,054
+10
| +0.3% | +$750 | 0.02% | 503 |
|
|
2022
Q1 | $238K | Sell |
3,044
-3
| -0.1% | -$235 | 0.02% | 539 |
|
|
2021
Q4 | $274K | Buy |
3,047
+4
| +0.1% | +$360 | 0.02% | 469 |
|
|
2021
Q3 | $281K | Buy |
3,043
+115
| +4% | +$10.6K | 0.02% | 433 |
|
|
2021
Q2 | $228K | Buy |
2,928
+10
| +0.3% | +$779 | 0.02% | 468 |
|
|
2021
Q1 | $217K | Buy |
2,918
+409
| +16% | +$30.4K | 0.02% | 454 |
|
|
2020
Q4 | $428K | Buy |
2,509
+4
| +0.2% | +$682 | 0.05% | 273 |
|
|
2020
Q3 | $352K | Sell |
2,505
-1,195
| -32% | -$168K | 0.05% | 275 |
|
|
2020
Q2 | $593K | Hold |
3,700
| – | – | 0.09% | 173 |
|
|
2020
Q1 | $402K | Buy |
+3,700
| New | +$402K | 0.07% | 197 |
|
|
2018
Q4 | – | Sell |
-5,503
| Closed | -$889K | – | 272 |
|
|
2018
Q3 | $889K | Buy |
+5,503
| New | +$889K | 0.22% | 82 |
|